SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001346302-21-000014
Filing Date
2021-02-01
Accepted
2021-02-01 16:20:53
Documents
1
Period of Report
2021-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161221443653827.html 4  
1 FORM 4 wf-form4_161221443653827.xml 4 3557
  Complete submission text file 0001346302-21-000014.txt   4993
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960
Business Address
Shannon John Patrick Jr (Reporting) CIK: 0001553595 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 21576942